Actively Recruiting
Artemis Sleep Countermeasures
Led by National Aeronautics and Space Administration (NASA) · Updated on 2024-08-01
24
Participants Needed
1
Research Sites
49 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Purpose. The purpose of this study is to test sleep and wake-promoting countermeasures to evaluate their effectiveness in helping individuals fall asleep quickly, maintain sleep during a nap, and maintain alertness during waking. Protocol Overview. The proposed study involves two laboratory visits separated by at least one week. Participants are required to complete all procedures in the companion screening and at-home protocol in order to qualify for this laboratory protocol. The at-home protocol involves keeping a regular schedule for 2-3 weeks. Participants will need to maintain a regular schedule with at least 8.5 hours in bed for at least one week prior to the first laboratory visit. They will then continue the at-home protocol, maintaining at least 8.5 hours in bed each night for at least a week before completing the second laboratory visit. There are two interventions that participants will experience during the study, sleep promoting (pink noise) and wake promoting (blue enriched lighting plus a nap). These will be delivered separately and together depending on randomization. Participants will first be randomized to one of three conditions sleep promoting + wake placebo, sleep placebo + wake promoting, or sleep promoting + wake promoting. All participants will complete a sleep placebo + wake placebo condition. The order of the full placebo condition versus the intervention (i.e., lab visit 1 vs. lab visit 2) will be randomized after the condition randomization occurs. Each participant will complete one of the interventions and one placebo for a total of two visits.
CONDITIONS
Official Title
Artemis Sleep Countermeasures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy individuals between the ages of 18 and 60
- Pre-menopausal individuals must be at least six months post-partum
- Pre-menopausal individuals must not be breastfeeding
- Pre-menopausal individuals must not be planning a pregnancy in the immediate future
You will not qualify if you...
- Body mass index (BMI) greater than 30
- Any sleep disorder
- Chronic conditions that affect sleep such as mood or eye disorders
- Chronic conditions interfering with data collection or safety such as cardiovascular disease, diabetes, or cancer
- Sensitive skin intolerant to electrode application
- Use of medications that interfere with sleep (e.g., anti-anxiety, antihistamines, antidepressants, beta blockers)
- Travel across more than two time zones or night shift work in the past month
- Pregnancy
- History of serious chronic conditions or mental illness including heart disease, cancer, seizures, respiratory diseases, sleep disorders, or Lupus
- Positive test for caffeine, alcohol, nicotine, or various drugs of abuse including amphetamines, barbiturates, benzodiazepines, cocaine, marijuana, MDMA, methadone, methamphetamines, opiates, oxycodones
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NASA Ames Research Center
Mountain View, California, United States, 94043
Actively Recruiting
Research Team
E
Erin E Flynn-Evans, PhD, MPH
CONTACT
N
Nicholas G Bathurst, MA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here